BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 19534508)

  • 1. Molecular modeling of the peptide agonist-binding site in a neurokinin-2 receptor.
    Chandrashekaran IR; Rao GS; Cowsik SM
    J Chem Inf Model; 2009 Jul; 49(7):1734-40. PubMed ID: 19534508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling of neurokinin B and tachykinin NK₃ receptor complex.
    Ganjiwale AD; Rao GS; Cowsik SM
    J Chem Inf Model; 2011 Nov; 51(11):2932-8. PubMed ID: 21913652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topological analysis of the complex formed between neurokinin A and the NK2 tachykinin receptor.
    Zoffmann S; Bertrand S; Do QT; Bertrand D; Rognan D; Hibert M; Galzi JL
    J Neurochem; 2007 Apr; 101(2):506-16. PubMed ID: 17402972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and pharmacological characterization of a hamster urinary bladder neurokinin A receptor cDNA.
    Aharony D; Little J; Thomas C; Powell S; Berry D; Graham A
    Mol Pharmacol; 1994 Jan; 45(1):9-19. PubMed ID: 8302285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of the aromatic residue at position 6 of [Nle(10)]neurokinin A(4-10) for binding to the NK-2 receptor and receptor activation.
    Gembitsky DS; Murnin M; Otvös FL; Allen J; Murphy RF; Lovas S
    J Med Chem; 1999 Jul; 42(15):3004-7. PubMed ID: 10425111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
    Yuzlenko O; Kieć-Kononowicz K
    J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Architecture of the human urotensin II receptor: comparison of the binding domains of peptide and non-peptide urotensin II agonists.
    Lavecchia A; Cosconati S; Novellino E
    J Med Chem; 2005 Apr; 48(7):2480-92. PubMed ID: 15801838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coupling interaction between thromboxane A2 receptor and alpha-13 subunit of guanine nucleotide-binding protein.
    Chou KC
    J Proteome Res; 2005; 4(5):1681-6. PubMed ID: 16212421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric functional switch of neurokinin A-mediated signaling at the neurokinin NK2 receptor: structural exploration.
    Valant C; Maillet E; Bourguignon JJ; Bucher B; Utard V; Galzi JL; Hibert M
    J Med Chem; 2009 Oct; 52(19):5999-6011. PubMed ID: 19746979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional model of the human urotensin-II receptor: docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model.
    Lescot E; Sopkova-de Oliveira Santos J; Colloc'h N; Rodrigo J; Milazzo-Segalas I; Bureau R; Rault S
    Proteins; 2008 Oct; 73(1):173-84. PubMed ID: 18409194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular domains of the neurokinin-1 receptor: structural characterization and interactions with substance P.
    Ulfers AL; Piserchio A; Mierke DF
    Biopolymers; 2002; 66(5):339-49. PubMed ID: 12539262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling studies on the human neuropeptide S receptor and its antagonists.
    Dal Ben D; Antonini I; Buccioni M; Lambertucci C; Marucci G; Vittori S; Volpini R; Cristalli G
    ChemMedChem; 2010 Mar; 5(3):371-83. PubMed ID: 20087922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The steric trigger in rhodopsin activation.
    Shieh T; Han M; Sakmar TP; Smith SO
    J Mol Biol; 1997 Jun; 269(3):373-84. PubMed ID: 9199406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane-induced structure of the mammalian tachykinin neuropeptide gamma.
    Chandrashekar IR; Dike A; Cowsik SM
    J Struct Biol; 2004 Dec; 148(3):315-25. PubMed ID: 15522780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conserved polar residues in the transmembrane domain of the human tachykinin NK2 receptor: functional roles and structural implications.
    Donnelly D; Maudsley S; Gent JP; Moser RN; Hurrell CR; Findlay JB
    Biochem J; 1999 Apr; 339 ( Pt 1)(Pt 1):55-61. PubMed ID: 10085227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding site analysis of full-length alpha1a adrenergic receptor using homology modeling and molecular docking.
    Pedretti A; Elena Silva M; Villa L; Vistoli G
    Biochem Biophys Res Commun; 2004 Jun; 319(2):493-500. PubMed ID: 15178433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis of natural ligand binding and activation of the Class II G-protein-coupled secretin receptor.
    Miller LJ; Dong M; Harikumar KG; Gao F
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):709-12. PubMed ID: 17635130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting automated G-protein coupled receptor modeling: the benefit of additional template structures for a neurokinin-1 receptor model.
    Kneissl B; Leonhardt B; Hildebrandt A; Tautermann CS
    J Med Chem; 2009 May; 52(10):3166-73. PubMed ID: 19397376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ligand binding site of the neurokinin 2 receptor. Site-directed mutagenesis and identification of neurokinin A binding residues in the human neurokinin 2 receptor.
    Bhogal N; Donnelly D; Findlay JB
    J Biol Chem; 1994 Nov; 269(44):27269-74. PubMed ID: 7961636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.